510(k) · Cleared
Recalled · Class II · 2018Apolipoprotein A1
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Abbott Laboratories · DER Alpha-1-Lipoprotein, Antigen, Antiserum, Control
Cleared on Jan 29, 1999 as substantially equivalent to K964292 (Crestat Diagnostics, Inc., 1997) after a 133-day review. Its family tree reaches back 1 generation to 1997. 1 later device descends from it. It has been recalled 2 times.
- Decided
- Jan 29, 1999
- Review
- 133 days
- Class
- Class II
- Product code
- DER
- Recalls
- 2
- Predicates
- 1
Its longest line of descent runs back 1 generation to K964292 (1997). 1 later device descends from it, 1 citing it directly.
Most influential descendants
Showing 1 of 1 · See all- K123372Abbott Lipid Multi Constituent CalibratorAbbott Laboratories · 2013 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K964292 | N-Assay Tia Apo A1 Test Kit | Crestat Diagnostics, Inc. | 1997 | — |
| 0 (this device) | K983289 | Apolipoprotein A1 | Abbott Laboratories | 1999 | — |
| +1 | K123372 | Abbott Lipid Multi Constituent Calibrator | Abbott Laboratories | 2013 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2013 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in DER? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K964292 | N-Assay Tia Apo A1 Test KitSummary page 2…onal to the concentration of apolipoprotein Al in the sample. Substantial Equivalence: The Apolipoprotein Al assay is substantially equivalent to the K-ASSAY® Apo Al (K964292) on the Hitachi® 717 Analyzer. Apolipoprotein A1 510(k) Section 11 September 17, 1998 Page 1 ApoA_Vliwp Q200014 === Page 3 ==… | 1997 |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K123372 | Abbott Lipid Multi Constituent Calibrator | 2013 | 0 |
Has anything in its family been recalled? (0 Class I)
Recalls of this device
| Date | Class | Recall | Root cause | Reason |
|---|---|---|---|---|
| May 16, 2018 | Class II | Z-1991-2019 | Under Investigation by firm | An update to the Reagents and Specimen Collection and Handling/Preparation for Analysis sections of the IFU was required due to different issues with the various products. |
| Nov 10, 2005 | Not classified | Z-0383-06 | Other | These specific protein assays are not meeting the 57-day on board stability claim |
No ancestor or descendant has a Class I recall.
What does this lineage say?
- Its one ancestor has no recall.
- Of its descendants, K123372 (Abbott Laboratories, 2013) has gone furthest, with 0 descendants of its own.
How does its category compare?
All DER devicesDER Alpha-1-Lipoprotein, Antigen, Antiserum, Control: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · DER
FDA has decided no DER device since 2007.
Median 510(k) review, days · DER
Too few DER 510(k)s in any year since 2007 to give a median.
Recalls per year · DER
No recall names DER since 2007.
Adverse event reports per year · DER
2in 2024
MAUDE reports naming product code DER, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 0 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 0 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 0 | — | 0 | 0 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 1 |
| 2024 | 0 | — | 0 | 2 |
| 2025 | 0 | — | 0 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The Apolipoprotein Al assay is used for the quantitation of apolipoprotein Al in human serum or plasma. Measurement of A lipoproteins, the major proteins found in HDL (high density lipoprotein), is used in the diagnosis and treatment of premature coronary artery disease, hyper-a-lipoproteinemia, and hypo-a-lipoproteinemia.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K983289 · printed Nov 5, 2026
Cite this page
510(k) Report. “K983289: Apolipoprotein A1.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K983289
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026